These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 7683622)

  • 21. [Current status of the clinical application of hematopoietic growth factors in oncology].
    Karthaus M; Ganser A
    Ther Umsch; 1996 Nov; 53(11):863-73. PubMed ID: 8984692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical use of growth factors in the myelodysplastic syndromes.
    Stein RS
    Am J Med Sci; 1994 May; 307(5):360-7. PubMed ID: 7513498
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical use of hematopoietic growth factors].
    Krusius T
    Duodecim; 1990; 106(7):547-9. PubMed ID: 1727024
    [No Abstract]   [Full Text] [Related]  

  • 24. Biological molecules in the treatment of hematological disorders.
    Kurzrock R; Talpaz M; Gutterman U
    Sangre (Barc); 1989 Feb; 34(1):53-8. PubMed ID: 2469130
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hematopoietic growth factors].
    Robak T
    Postepy Hig Med Dosw; 1991; 45(6):461-96. PubMed ID: 1726024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of bone marrow transplantation in the treatment of myelodysplastic syndromes.
    Schultz AB; Geller RB; Hillyer CD
    J Hematother; 1995 Aug; 4(4):323-34. PubMed ID: 7489147
    [No Abstract]   [Full Text] [Related]  

  • 27. Hematopoietic growth factors in cancer chemotherapy.
    Morstyn G; Foote M; Lieschke GJ
    Cancer Chemother Biol Response Modif; 1996; 16():295-314. PubMed ID: 8639388
    [No Abstract]   [Full Text] [Related]  

  • 28. Do haemopoietic growth factors increase the efficacy of aggressive therapy of ANLL in elderly patients?
    Mandelli F; Petti MC
    Hematol Oncol; 1993; 11 Suppl 1():9-11. PubMed ID: 7683626
    [No Abstract]   [Full Text] [Related]  

  • 29. [Use of hematopoietic growth factors].
    Elonen E
    Duodecim; 1995; 111(8):733-40. PubMed ID: 8681833
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hematopoietic growth factors in the limelight. New actors on the pharmacotherapeutic stage].
    Löwenberg B
    Ned Tijdschr Geneeskd; 1991 Mar; 135(10):407-9. PubMed ID: 1708442
    [No Abstract]   [Full Text] [Related]  

  • 31. Recombinant hematopoietic growth factors in bone marrow transplantation.
    Nemunaitis J
    Cancer Treat Res; 1995; 76():225-48. PubMed ID: 7577337
    [No Abstract]   [Full Text] [Related]  

  • 32. In vivo biology and therapeutic potential of hematopoietic growth factors and circulating progenitor cells.
    Herrmann F; Brugger W; Kanz L; Mertelsmann R
    Semin Oncol; 1992 Aug; 19(4):422-31. PubMed ID: 1380732
    [No Abstract]   [Full Text] [Related]  

  • 33. Hematopoietic growth factors for hematopoietic stem cell mobilization and expansion.
    Möhle R; Kanz L
    Semin Hematol; 2007 Jul; 44(3):193-202. PubMed ID: 17631183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haematopoietic growth factors in the treatment of myelodysplastic syndromes.
    Cazzola M
    Forum (Genova); 1999; 9(1):49-57. PubMed ID: 10101210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hematopoietic growth factors in cancer chemotherapy.
    Morstyn G; Lieschke GJ
    Cancer Chemother Biol Response Modif; 1994; 15():367-90. PubMed ID: 7540031
    [No Abstract]   [Full Text] [Related]  

  • 36. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The strategy for the treatment of myelodysplastic syndromes].
    Hideaki M
    Rinsho Ketsueki; 2002 Mar; 43(3):157-60. PubMed ID: 11979745
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hematopoietic tissue growth factors: clinical factors].
    Polli EE; Foa P
    Ann Ital Med Int; 1991; 6(1 Pt 1):69-81. PubMed ID: 1716450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined use of erythropoietin and G-CSF in the treatment of myelodysplastic syndromes.
    Haematologica; 1999 Dec; 84(12):1057. PubMed ID: 10586204
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical trials of myeloid growth factors.
    Glaspy JA; Golde DW
    Exp Hematol; 1990 Nov; 18(10):1137-41. PubMed ID: 1698650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.